A list of puns related to "Allergan, Inc"
Allergan is a multi-specialty health care firm who develops and commercializes medical applications which include: ophthalmic (vision), neurological (nervous system), aesthetics (cosmetic surgery), dermatology (skin disorders), obesity, and urological.
I previously recommended Autoliv (NYSE:ALV) but realized the portfolio is too concentrated in the auto sector given that Ford and Tesla have been picked.
Allergan has a market cap of over $27 billion, forward P/E at approximately 19, PEG at approximately 2. Quick ratio at approximately 4, D/E at approximately 0.3 and it pays out a small dividend with a yield just above 0.2% and a payout ratio of around 6%. Revenue growth has averaged approximately 9% every year for the past decade, cash flows from operations and R&D expenses have held steady in the $200 million range for the past decade. It has sales all over the world with a solid product line in separate distinct medical specialties. For further details and other stats, please see references below.
I believe Allergan is a solid long-term buy for one main reason, demographics. As the population ages, healthcare spending is expected to increase. The bulk of Allergan’s net sales come from eye care, notably Restasis (dry eyes) and Lumigan (Glaucoma). Note that Glaucoma is the seconding leading cause of blindness (more stats in the references link). Aesthetics is another major area the firm specializes in. With an aging population and the media constantly encouraging perfection, this is another area that I expect significant growth. Allergan’s products include skin care, breast aesthetics and facial aesthetics. Lastly, I would also like to touch on Allergan’s obesity intervention product line (Lap-Band). America’s fight with obesity is largely publicized; however, China with a massive population is also showing signs of obesity problems. This is another potential large market for Allergan. Also note that as China’s wealth increases, demand for cosmetic/aesthetics will also increase providing yet another source of growth.
For the sake of a Reddit post, I will end it here. Of course, there is much more research that should be included including competitors, currency risk, other risk factors, etc., however I will just leave some links below for reference and let others mention them in the comments section.
Note: I personally would like to s
... keep reading on reddit ➡Do your worst!
Please note that this site uses cookies to personalise content and adverts, to provide social media features, and to analyse web traffic. Click here for more information.